ABCA7 — The Brain's Lipid-Linked Garbage Collector
Your brain generates amyloid-beta peptides continuously, and healthy ageing depends on clearing them
efficiently. ABCA7 — an ATP-binding cassette transporter expressed most highly in microglia and
excitatory neurons — sits at the intersection of this clearance system and the brain's lipid economy.
The rs78117248 variant is an intronic marker that tags an expanded VNTR11 tags an expanded VNTR
Variable Number Tandem Repeat:
a stretch of repeating DNA in intron 18 of ABCA7 that can expand beyond 5.6 kb,
disrupting how the gene is read and the protein it produces.
The Mechanism
rs78117248 itself is a deep intronic SNP with no direct effect on protein sequence. Its significance comes from what it tracks: carriers of the G allele are significantly more likely to carry an expanded VNTR in ABCA7 intron 1822 VNTR in ABCA7 intron 18. When this repeat expands beyond roughly 5.6 kb, two things happen: overall ABCA7 expression falls (the expanded repeat recruits transcriptional repressors including ZNF263 and PLAG1), and exon 19 is skipped during mRNA splicing33 exon 19 is skipped during mRNA splicing, removing 44 amino acids from the first nucleotide-binding domain of the protein.
The downstream effects cascade through two well-characterised pathways. First, microglia lacking functional ABCA7 cannot efficiently engulf amyloid-beta oligomers44 cannot efficiently engulf amyloid-beta oligomers — in mouse knockouts, hippocampal amyloid clearance is substantially reduced both in cell culture and in the living brain. Second, excitatory neurons with ABCA7 loss-of-function show disrupted phosphatidylcholine metabolism, impaired mitochondrial respiration, elevated oxidative stress, and increased amyloid-beta secretion55 disrupted phosphatidylcholine metabolism, impaired mitochondrial respiration, elevated oxidative stress, and increased amyloid-beta secretion — a constellation of changes that mirrors early-stage Alzheimer's pathology.
The Evidence
The VNTR expansion study66 VNTR expansion study
De Roeck et al. An intronic VNTR affects splicing of ABCA7 and increases
risk of Alzheimer's disease. Acta Neuropathol. 2018
showed that expanded alleles were present in 7.3% of AD patients versus 1.7% of controls in a
Belgian cohort (OR 4.5, 95% CI 1.3–24.2). rs78117248 was in strong LD with all three major
European GWAS sentinel SNPs for ABCA7 (rs3764650, rs4147929, rs3752246).
A comprehensive 2024 review by Duchateau et al. Alzheimer's & Dementia. 202477 Duchateau et al. Alzheimer's & Dementia. 2024 quantified rs78117248's population-level effect at OR 1.16 (95% CI 1.11–1.20, p = 8.47 × 10⁻⁹) — a modest but robustly replicated association consistent with rs78117248 being an incomplete tag for the higher-penetrance VNTR expansion. The VNTR expansion itself explains the apparently paradoxical finding that this intronic SNP outperforms the coding GWAS variants as a statistical predictor of AD.
Practical Actions
rs78117248 G carriers face approximately 1.15–1.20-fold elevated AD risk at the population level, with the subset who carry an expanded VNTR facing roughly 4-fold higher risk.
Cognitive monitoring — baseline neuropsychological testing followed by regular reassessment — enables early detection of decline when interventions are most effective.